Ken Griffin Beyond Air, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Beyond Air, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 37,100 shares of XAIR stock, worth $6,678. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,100
Previous 20,400
81.86%
Holding current value
$6,678
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding XAIR
# of Institutions
49Shares Held
19.2MCall Options Held
37.1KPut Options Held
9.2K-
Alyeska Investment Group, L.P. Chicago, IL7.14MShares$1.29 Million0.01% of portfolio
-
Balyasny Asset Management LLC Chicago, IL3.33MShares$600,1930.0% of portfolio
-
Lasry Marc New York, NY1.64MShares$295,0235.51% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$227,6120.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY937KShares$168,6020.03% of portfolio
About Beyond Air, Inc.
- Ticker XAIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 29,888,000
- Market Cap $5.38M
- Description
- Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...